Aureobasidium.org

In Vivo 2023

Low-Molecular-Weight β-1,3-1,6-Glucan Derived from Aureobasidium pullulans Exhibits Anticancer Activity by Inducing Apoptosis in Colorectal Cancer Cells

Kim, Ji Hyeon; Seo, Jeonghyeon; No, Huiwon; Kuge, Takao; Mori, Takahiro; Kimoto, Hisashi; Kim, Jin-Kyung · Biomedicines · DOI: 10.3390/biomedicines11020529 · PMID: 36831065
Research Archive
TL;DR — Key Findings
  • In BALB/c mice bearing CT-26 tumors, LMW-AP-FBG given for two weeks reduced tumor growth versus buffer-treated controls.
  • The study also reported dose-dependent loss of CT-26 cell viability and apoptosis-related changes in vitro.
  • Preclinical mouse and cell study; it does not establish anticancer efficacy or safety in humans.

Abstract

β-glucan, a plant polysaccharide, mainly exists in plant cell walls of oats, barley, and wheat. It is attracting attention due to its high potential for use as functional foods and pharmaceuticals. We have previously reported that low-molecular-weight Aureobasidium pullulans-fermented β-D-glucan (LMW-AP-FBG) could inhibit inflammatory responses by inhibiting mitogen-activated protein kinases and nuclear factor-κB signaling pathways. Bases on previous results, the objective of the present study was to investigate the therapeutic potential of LMW-AP-FBG in BALB/c mice intracutaneously transplanted with CT-26 colon cancer cells onto their backs. Daily intraperitoneal injections of LMW-AP-FBG (5 mg/kg) for two weeks significantly suppressed tumor growth in mice bearing CT-26 tumors by reducing tumor proliferation and inducing apoptosis as compared to phosphate buffer-treated control mice. In addition, LMW-AP-FBG treatment reduced the viability of CT-26 cells in a dose-dependent manner by inducing apoptosis with loss of mitochondrial transmembrane potential and increased activated caspases. Taken together, LMW-AP-FBG exhibits anticancer properties both in vivo and in vitro.

Summary

Summary

Background

This preclinical study evaluated low-molecular-weight Aureobasidium pullulans-fermented beta-glucan (LMW-AP-FBG) in a CT-26 colorectal cancer model.

Methods and results

BALB/c mice bearing CT-26 tumors received daily intraperitoneal LMW-AP-FBG for two weeks. The study reported reduced tumor growth compared with buffer-treated controls. Separate cell experiments reported dose-dependent loss of viability and apoptosis-related changes.

Interpretation

The evidence comes from mouse and cell models. It does not demonstrate anticancer efficacy, clinical benefit, or safety in humans.

AI-generated summary for accessibility. Always refer to the original paper.

Keywords

colorectal cancer apoptosis beta glucan Aureobasidium pullulans caspase Bcl-2 Bax low molecular weight anti-cancer tumor suppression

Citation

Kim, Ji Hyeon; Seo, Jeonghyeon; No, Huiwon; Kuge, Takao; Mori, Takahiro; Kimoto, Hisashi; Kim, Jin-Kyung. Low-Molecular-Weight β-1,3-1,6-Glucan Derived from Aureobasidium pullulans Exhibits Anticancer Activity by Inducing Apoptosis in Colorectal Cancer Cells. Biomedicines. 2023. DOI: 10.3390/biomedicines11020529. PMID: 36831065.

Study Details
Study Type
In Vivo
Published
2023
Journal
Biomedicines
Authors
Kim, Ji Hyeon; Seo, Jeonghyeon; No, Huiwon; Kuge, Takao; Mori, Takahiro; Kimoto, Hisashi; Kim, Jin-Kyung
PubMed ID
36831065
Important Notice

For scientific reference only. Not medical advice. Consult a qualified healthcare professional. See our Medical Disclaimer.